Skip to main content

Research Repository

Advanced Search

Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure: A Meta-Analysis of Randomized Controlled Trials

Ciani, Oriana; Piepoli, Massimo; Smart, Neil; Uddin, Jamal; Walker, Sarah; Warren, Fiona C.; Zwisler, Ann D.; Davos, Constantinos H.; Taylor, Rod S.

Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure: A Meta-Analysis of Randomized Controlled Trials Thumbnail


Authors

Oriana Ciani

Massimo Piepoli

Neil Smart

Jamal Uddin

Fiona C. Warren

Ann D. Zwisler

Constantinos H. Davos

Rod S. Taylor



Abstract

Objectives: This study sought to validate exercise capacity (EC) as a surrogate for mortality, hospitalization, and health-related quality of life (HRQOL). Background: EC is often used as a primary outcome in exercise-based cardiac rehabilitation (CR) trials of heart failure (HF) via direct cardiorespiratory assessment of maximum oxygen uptake (VO2peak) or through submaximal tests, such as the 6-min walk test (6MWT).

Methods: After a systematic review, 31 randomized trials of exercise-based CR compared with no exercise control (4,784 HF patients) were included. Outcomes were pooled using random effects meta-analyses, and inverse variance weighted linear regression equations were fitted to estimate the relationship between the CR on EC and all-cause mortality, hospitalization, and HRQOL. Spearman correlation coefficient (ρ), R2 at trial level, and surrogate threshold effect (STE) were calculated. STE represents the intercept of the prediction band of the regression line with null effect on the final outcome.

Results: Exercise-based CR is associated with positive effects on EC measured through VO2peak (+3.10 ml/kg/min; 95% confidence interval [CI]: 2.01 to 4.20) or 6MWT (+41.15 m; 95% CI: 16.68 to 65.63) compared to control. The analyses showed a low level of association between improvements in EC (VO2peak or 6MWT) and mortality and hospitalization. Moderate levels of correlation between EC with HRQOL were seen (e.g., R2 <52%; |ρ| < 0.72). Estimated STE was an increase of 5 ml/kg/min for VO2peak and 80 m for 6MWT to predict a significant improvement in HRQOL.

Conclusions: The study results indicate that EC is a poor surrogate endpoint for mortality and hospitalization but has moderate validity as a surrogate for HRQOL. Further research is needed to confirm these findings across other HF interventions.

Citation

Ciani, O., Piepoli, M., Smart, N., Uddin, J., Walker, S., Warren, F. C., Zwisler, A. D., Davos, C. H., & Taylor, R. S. (2018). Validation of Exercise Capacity as a Surrogate Endpoint in Exercise-Based Rehabilitation for Heart Failure: A Meta-Analysis of Randomized Controlled Trials. JACC: Heart Failure, 6(7), 596-604. https://doi.org/10.1016/j.jchf.2018.03.017

Journal Article Type Article
Acceptance Date Mar 27, 2018
Online Publication Date Jun 25, 2018
Publication Date 2018-07
Deposit Date Jun 9, 2025
Publicly Available Date Jun 9, 2025
Journal JACC: Heart Failure
Print ISSN 2213-1779
Electronic ISSN 2213-1787
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 6
Issue 7
Pages 596-604
DOI https://doi.org/10.1016/j.jchf.2018.03.017
Keywords 6-min walk test, exercise capacity, heart failure, maximum oxygen uptake, surrogate outcomes
Public URL https://nottingham-repository.worktribe.com/output/49562600
Publisher URL https://www.sciencedirect.com/science/article/pii/S2213177918302324?via%3Dihub

Files

Validation Of Exercise Capacity As A Surrogate Endpoint In Exercise-Based Rehabilitation For Heart Failure: A Meta-Analysis Of Randomized Controlled Trials (702 Kb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/

Copyright Statement
© 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).





You might also like



Downloadable Citations